Acura Pharmaceuticals
NASDAQ:ACUR (2/22/2017, 7:10:00 PM)
After market: 0.61 -0.01 (-1.61%)0.62
-0.16 (-20.51%)
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Acura Pharmaceuticals
616 N. NORTH COURT SUITE 120
PALATINE IL 60067
P: 847-705-7709
CEO: Robert B. Jones
Amendment Extends NDA Acceptance Date...
PALATINE, Ill., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that the LTX-03 (hydrocodone bitartrate and...
PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research,...
Amendment Extends NDA Acceptance Date
Here you can normally see the latest stock twits on ACUR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: